Life sciences firm Avesthagen, on Friday, said it has signed an agreement with Bangalore-based Kemwell Biopharma to leverage the latter’s expertise for large scale manufacture of biosimiliars.
As per the MoU, “Kemwell will perform technology transfer, process improvement, scale-up and manufacturing of pre-clinical, clinical and commercial material of Avesthagen biosimilars,” Avesthagen Ltd said in a statement.
Biosimilars are subsequent versions of innovator biopharmaceutical products made by a different firm following patent and exclusivity expiry on the innovator product.
Published 13 May 2011, 16:31 IST